Mylan Institutional LLC drugs

33 results

  • Baclofen (baclofen)

    (baclofen)
    Mylan Institutional LLC
    Usage: Baclofen injection is indicated for managing severe spasticity in adults and pediatric patients (ages 4 and above). It should be used after a positive response to a screening dose, mainly for spinal cord-related spasticity in patients unresponsive to oral therapy or intolerant of side effects.

  • Dexamethasone sodium phosphate (dexamethasone sodium phosphate)

    (Dexamethasone Sodium Phosphate)
    Mylan Institutional LLC
    Usage: This drug is indicated for various conditions, including adrenal insufficiencies, rheumatic disorders, collagen diseases, severe allergic reactions, ophthalmic, gastrointestinal, respiratory, hematologic, and neoplastic diseases, and for reducing edema. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally, depending on the condition.

  • Dexamethasone sodium phosphate (dexamethasone sodium phosphate)

    (Dexamethasone Sodium Phosphate)
    Mylan Institutional LLC
    Usage: This drug is indicated for various conditions including adrenocortical insufficiency, rheumatic and collagen diseases, severe allergic reactions, ophthalmic and respiratory diseases, gastrointestinal diseases, hematologic disorders, neoplastic diseases, and cerebral edema. It can be administered via intravenous, intramuscular, intra-articular, or intralesional injections.

  • Diazepam (diazepam)

    (diazepam)
    Mylan Institutional LLC
    Usage: Diazepam tablets are indicated for managing anxiety disorders, providing short-term relief of anxiety symptoms, aiding in acute alcohol withdrawal, relieving muscle spasms, and as an adjunct in convulsive disorders. Long-term effectiveness beyond four months is not established; periodic reassessment is recommended.

  • Diphenhydramine hydrochloride (diphenhydramine hydrochloride)

    (diphenhydramine hydrochloride)
    Mylan Institutional LLC
    Usage: Diphenhydramine hydrochloride injection is indicated for allergic reactions, anaphylaxis (with epinephrine), motion sickness, and parkinsonism in cases where oral administration is impractical. It is effective for adults and pediatric patients, excluding premature infants and neonates.

  • Divalproex sodium (divalproex sodium)

    (divalproex sodium)
    Mylan Institutional LLC
    Usage: Divalproex sodium extended-release tablets are indicated for treating acute manic or mixed episodes in bipolar disorder, epilepsy (complex partial and absence seizures), and for migraine prophylaxis. It should not be used in women of childbearing potential without effective contraception due to significant fetal risks.

  • Docetaxel (docetaxel)

    (Docetaxel)
    Mylan Institutional LLC
    Usage: Docetaxel Injection is indicated for treating locally advanced or metastatic breast cancer, non-small cell lung cancer, metastatic castration-resistant prostate cancer, advanced gastric adenocarcinoma, and locally advanced head and neck cancer, often in combination with other chemotherapy agents, after prior treatments have failed.

  • Epoprostenol (epoprostenol)

    (EPOPROSTENOL)
    Mylan Institutional LLC
    Usage: Epoprostenol for injection is indicated for treating pulmonary arterial hypertension (PAH) to improve exercise capacity, primarily in patients with NYHA Functional Class III-IV symptoms, including those with idiopathic, heritable PAH, or PAH associated with connective tissue diseases.

  • Eptifibatide (eptifibatide)

    (eptifibatide)
    Mylan Institutional LLC
    Usage: Eptifibatide injection is indicated for reducing the risk of death or new myocardial infarction in patients with acute coronary syndrome (ACS) and for decreasing complications in patients undergoing percutaneous coronary intervention (PCI), including those receiving intracoronary stenting.

  • Fosaprepitant (fosaprepitant)

    (fosaprepitant)
    Mylan Institutional LLC
    Usage: Fosaprepitant for injection is indicated for preventing acute and delayed nausea and vomiting in adults associated with highly and moderately emetogenic chemotherapy, including high-dose cisplatin. It has not been studied for treating established nausea and vomiting. Pediatric usage information exists but is not included in this product's labeling.